Hematologic Malignancies Testing Market Size, Share Analysis and Growth Forecast 2030
The global Hematologic Malignancies Testing Market had a size of USD 2.55 billion in 2021 and is expected to grow at a CAGR of 14.7% during the forecast period. Hematologic malignancies are cancers that develop in blood, bone marrow, and lymph nodes. The rising prevalence of blood cancer, leukemia, and multiple myeloma worldwide, increasing healthcare spending, awareness among patients and healthcare professionals about early diagnosis, and the development of a strong product pipeline are the main factors driving market revenue growth. Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5908 Hematologic malignancies are one of the leading causes of death in the U.S., accounting for 9.5% of cancer deaths in 2021, and the incidence rates of non-Hodgkin's lymphoma and leukemia have surged by approximately 40% and 25%, respectively. Key players in the Hematologic Malignancies Testing Market – · I...